SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by SELLAS Life Sciences Group, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for SELLAS Life Sciences Group, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Stergiou Angelos M. | President and CEO | 1,759,183 | Jun 18, 2026 | 2 |
| Van Nostrand Robert L | Director | 82,900 | Jan 9, 2026 | 1 |
| Scheinberg David A | Director | 73,082 | Jan 9, 2026 | 1 |
| Wasman Jane | Director | 92,900 | Jan 9, 2026 | 1 |
| Varian John | Director | 72,900 | Jan 9, 2026 | 1 |
| Cicic Dragan | SVP, Chief Development Officer | 557,805 | Jan 9, 2026 | 2 |
| Burns John Thomas | CFO | 554,327 | Jan 9, 2026 | 2 |
| Kalin Katherine Bach | Director | 154,400 | Jan 9, 2026 | 2 |
| Wood Barbara A | EVP, Gen. Counsel, Corp. Sec. | 117,225 | Jan 25, 2024 | 0 |
| Francomano Robert | Chief Commercial Officer | 40,918 | Jan 25, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 (view filing) | Nov 19 | 2 days | Kalin Katherine BachDirector | PPurchase | +63.4K | $1.59 | +$100.8K | +154.6%104.4K after | |
| Jun 13, 2025 (view filing) | Jun 12 | 1 day | Van Nostrand Robert LDirector | PPurchase | +10.0K | $1.48 | +$14.8K | +96.2%20.4K after | |
| Jun 2, 2025 (view filing) | May 30 | 3 days | Wasman JaneDirector | PPurchase | +20.0K | $1.69 | +$33.8K | +192.3%30.4K after | |
| May 22, 2025 (view filing) | May 22 | Same day | Kalin Katherine BachDirector | PPurchase | +20.0K | $1.80 | +$36.0K | +95.2%41.0K after | |
| Dec 5, 2022 (view filing) | Dec 5 | Same day | Stergiou Angelos M.President and CEO | SSaleClass A Common Stock | −6.49K | $2.61 | −$16.9K | −3.9%161.7K after | |
| Dec 5, 2022 (view filing) | Dec 5 | Same day | Burns John ThomasSenior VP, Finance & CAO | SSaleClass A Common Stock | −1.16K | $2.59 | −$3.00K | −3.8%29.3K after | |
| Dec 5, 2022 (view filing) | Dec 5 | Same day | Wood Barbara AEVP, Gen. Counsel, Corp. Sec. | SSaleClass A Common Stock | −2.15K | $2.59 | −$5.58K | −3.7%56.3K after | |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Stergiou Angelos M.President and CEO | SSale | −2.12K | $6.25 | −$13.3K | −1.7%121.2K after | |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Wood Barbara AEVP, Gen. Counsel, Corp. Sec. | SSale | −847 | $6.25 | −$5.29K | −2.0%42.0K after | |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Burns John ThomasVP, Finance & Corp Controller | SSale | −231 | $6.27 | −$1.45K | −1.3%17.6K after |